Skip to main content

Clinical Cellular Therapy Research Laboratory (LTCC)

Description

The Institut Bordet Clinical Cellular Therapy Research Laboratory (LTCC) is dedicated to fundamental and translational research in the fields of haematology and immunology cellular therapy.

The LTCC’s main objectives concern:

  • study of the interaction between leukaemic cells and their microenvironment;
  • establishment of new prognostic factors;
  • development of new therapeutic strategies.

Within the field of cellular therapy, the LTCC is studying the functional characterisation of mesenchymal stromal cells obtained from different tissues and their manipulation with a view to increasing their therapeutic potential.

Research projects

Project 1

IMPACT OF CHRONIC LYMPHOCYTIC LEUKEMIA-DERIVED EXTRACELLULAR VESICLES ON THE MICROENVIRONMENT IMMUNE LANDSCAPE / IMPACT DES VÉSICULES EXTRACELLULAIRES DÉRIVÉES DE LEUCÉMIE LYMPHOÏDE CHRONIQUE SUR LES CELLULES IMMUNITAIRES DU MICROENVIRONNEMENT

Project 2

Phenotypical Characterization and functional Impact of extracellular vesicles from mesenchymal stromal cells on Chronic Lymphocytic Leukemia B-cells

Project 3

Extracellular vesicles derived from umbilical cord-mesenchymal stromal cells for targeted therapy in pancreatic cancer

Project 4

Immunosuppressive microenvironment in multiple myeloma: role of bone marrow-mesenchymal cell (BM-MSC) glycosylation

Project 5

The use of Adipose Tissue derived Stromal Vascular Fraction in a Platelet-Rich Fibrin scaffold within Medication-Related Osteonecrosis of the Jaw treatment
  • Project leader : Cyril Bouland  
  • Collaboration : Nathalie Meuleman, Isabelle Loeb
  • Funding : Fondation Vésal

Our team

Laboratory head
Laurence Lagneaux, PhD

The team
Basile Stamatopoulos, PhD
Karlien Pieters, laboratory technician
Florian Draguet, PhD student Télévie
Nathan Dubois, PhD student Télévie
Cyril Bouland, MD, PhD student
Florent Corrillon, scientific collaborator

 Scientific publications

Inflammation Differentially Modulates the Biological Features of Adult Derived Human Liver Stem/Progenitor Cells.

Authors : El-Kehdy H, Najar M, De Kock J, Agha DM, Rogiers V, Merimi M, Lagneaux L, Sokal EM, Najimi M
Year : 2020
Journal : Cells
Volume : 9

Mesenchymal Stem/Stromal Cells in Immunity and Disease: A Better Understanding for an Improved Use.

Authors : Merimi M, Lagneaux L, Moussa Agha D, Lewalle P, Meuleman N, Burny A, Fahmi H, Najar M
Year : 2020
Journal : J Clin Med
Volume : 9

Inflammation Alters the Secretome and Immunomodulatory Properties of Human Skin-Derived Precursor Cells.

Authors : De Kock J, Rodrigues RM, Branson S, Verhoye L, Colemonts-Vroninks H, Rombaut M, Boeckmans J, Neuckermans J, Lequeue S, Buyl K, Merimi M, Agha DM, De Boe V, Lagneaux L, Meuleman P, Vanhaecke T, Najar M
Year : 2020
Journal : Cells
Volume : 9

The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells.

Authors : Buyl K, Merimi M, Rodrigues RM, Agha DM, Melki R, Vanhaecke T, Bron D, Lewalle P, Meuleman N, Fahmi H, Rogiers V, Lagneaux L, Kock J, Najar M
Year : 2020
Journal : J Clin Med
Volume : 9

Triple negative breast cancer: microRNA expression profile and novel discriminators according to BRCA1 status.

Authors : Abdel-Sater F, Najar M, Fayyad-Kazan H
Year : 2020
Journal : J Cell Physiol
Volume : 235
Pages : 5204-5212